This session aims to inform developers of innovative therapies & technologies, how they can interact with medicine regulators to seek support, and how regulators use these interactions to advance the system and prepare for their arrival.
Learning Objectives
Discuss the offer of early point of contact (EPOC) at the EMA; Identify topics in R&D that are suitable for EPOC interactions; Explain the potential added value of EPOC interactions for developers (direct and indirect benefits) and for regulators (medicine regulators, HTA and other official bodies); Identify how to create links and opportunities for public private partnership engagement.
Monday June 26, 2023 4:15pm - 5:15pm CDT
TBDBoston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
